Detalhe da pesquisa
1.
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common ß-chain cytokine receptor endocytosis.
Blood
; 139(5): 761-778, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780648
2.
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1): 43-69, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394770
3.
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Eur J Haematol
; 111(6): 863-871, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670560
4.
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Cancer
; 128(7): 1411-1417, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931301
5.
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia.
Haematologica
; 107(11): 2641-2649, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511672
6.
The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis.
Haematologica
; 105(1): 136-147, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018977
7.
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(10): 1385-1415, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022644
8.
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(9): 1248-1269, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886902
9.
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
BMC Cancer
; 18(1): 359, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609532
10.
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(12): 1500-1537, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545997
11.
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Am J Hematol
; 93(11): 1301-1310, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074259
12.
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 17(5): 612-21, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083332
13.
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Pediatr Blood Cancer
; 63(12): 2096-2103, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511899
14.
Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
Nature
; 466(7307): 765-8, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20639863
15.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409798
16.
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood
; 118(17): 4561-6, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873548
17.
Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms.
J Mol Diagn
; 25(12): 932-944, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813298
18.
Discovery of U2AF1 neoantigens in myeloid neoplasms.
J Immunother Cancer
; 11(12)2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164756
19.
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.
Clin Cancer Res
; 29(12): 2179-2183, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547666
20.
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
JAMA Netw Open
; 6(12): e2347950, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109114